Current and future perspective of registry utilisation for regulatory settings in Japan: pharmaceuticals, medical devices, and regenerative medicine products
Considerable attention has been paid to the utilisation of real-world data throughout the lifecycle of pharmaceuticals, medical devices, and regenerative products. In Japan, regulatory initiatives have been implemented to promote the utilisation of real-world data and evidence for regulatory decisio...
Saved in:
| Main Authors: | Chieko Ishiguro, Yasutomo Teshima, Harumasa Nakamura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Journal of Pharmaceutical Policy and Practice |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20523211.2025.2523935 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Research on Application of Medical Device Real-World Evidence in Regulatory Decisions of the United States
by: Xiaofang GU, et al.
Published: (2025-07-01) -
Use of real-world data as pivotal evidence in veterinary regulatory applications
by: Raffaele Bruno
Published: (2025-06-01) -
Real-World Evidence and Managed Entry Agreements
by: Silvia Adami, et al.
Published: (2025-07-01) -
Real-world evidence of biological treatments in rheumatoid arthritis and spondyloarthritis in Morocco: results of the RBSMR registry
by: Najlae El Ouardi, et al.
Published: (2025-05-01) -
Clinical impact of inappropriate DOAC dosing in atrial fibrillation: Insights from a real-world registry
by: Mustafa Yildirim, et al.
Published: (2025-02-01)